Please read and follow these instructions.

Registered Delegate and Presenting Author: The presenting author must be the first author of the abstract, and must be registered as a delegate for the meeting.

Abstract Content: Each abstract should contain the following elements:

- a sentence stating the study objective (unless given in the title)
- a brief statement of methods
- a summary of the results obtained
- a statement of the conclusions
- acknowledgements of funding source(s)
- it is not satisfactory to say "the results will be discussed"
- limit your abstract body to 300 words

Fonts and Symbols: Use the Times New Roman font for the entire abstract. If you need special symbols, use either the Times New Roman or Symbol fonts (special fonts like WP Extended Greek will not work). Be very careful to proofread your abstract for alterations in the symbols.

Title: Use a short, specific and declarative title. The abstract title should be prepared in UPPERCASE.

Tables and Figures: No tables or figures are allowed.

Abbreviations: Use standard abbreviations for units of measure. Other abbreviations should be spelled out in full at first mention, followed by the abbreviation in parentheses. Exceptions: DNA, RNA, etc.

Length: The abstract title and abstract body combined should not exceed 300 words. Most word processing programs have built-in word count utilities—use them!

Word Processor: Prepare your abstract in any word processor format--you will be cutting and pasting into the abstract submission form. Margin settings and font size do not matter.

Note: The majority of presentations will be in poster symposia.

Notification of Programming: The presenting author will be notified by email by early January concerning the title, date and time of the session for which their abstract is scheduled, the format of presentation (oral, poster or both), and the specific presentation time. It is up to the presenting author to advise coauthors of the time of the presentation.

References: If you choose to include references, please use Journal of Applied Physiology reference style.

If you are still not sure how to put your abstract together, here is an example from our last live meeting:

THE EFFECT OF AN EXPIRATORY RESISTANCE MASK WITH DEAD SPACE ON SLEEP, ACUTE MOUNTAIN SICKNESS, COGNITION AND VENTILATORY ACCLIMATIZATION IN NORMOBARIC HYPOXIA Alexander Patrician, Michael M Tymko, Hannah G Caldwell, Connor A Howe, Geoff B Coombs, Rachel Stone, Allison Hamilton, Ryan L Hoiland, Philip N Ainslie University British Columbia Okanagan, Canada; amdpatrician@gmail.com

Objective: We examined the hypothesis that an expiratory resistance mask containing a small amount of dead-space (ER/DS) would reduce the apnea-hypopnea index (AHI) during sleep, attenuate the severity of acute mountain sickness (AMS), and offset decrements in cognitive function compared to a sham mask. Methods: In a double-blinded, randomized, sham-controlled, cross-over design, 19 volunteers were exposed to two nights of normobaric hypoxia (FIO2 = 0.125), using an ER/DS mask (3.5 mm restrictive expiratory orifice; 125 mL dead-space volume) and sham mask (zero-flow resistance; 50 mL dead-space volume). Cognitive function, AMS, and ventilatory acclimatization were assessed before and after the 12-hour normobaric hypoxia exposure. Polysomnography was conducted during sleep. Results: AHI was reduced using the ER/DS sleep mask compared to the sham (30.1 ± 23.9 events·hr-1 vs. 58.9 ± 34.4 events·hr-1, respectively; p=0.01). Likewise, oxygen desaturation index and headache severity were reduced (both p<0.05). There were also benefits on limiting the hypoxia-induced reductions in select measures of reaction speed and attention (p<0.05). Conclusion: Our study indicates that a simple non-invasive and portable ER/DS mask resulted in reductions (49%) in AHI, and reduced headache severity and aspects of cognitive decline. The field applications of this ER/DS mask should be investigated further before recommendations can be made to support its benefit for travel to high altitude. Funding: The study was sponsored by Trudell Medical International.